JMP Securities Sticks to Its Buy Rating for Bicycle Therapeutics (BCYC)
In a report released today, Reni Benjamin from JMP Securities reiterated a Buy rating on Bicycle Therapeutics (BCYC – Research Report), wi...
Source: businessinsider.com
John Tite News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from John Tite. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In John Tite Today - Breaking & Trending Today
Bicycle Therapeutics (NASDAQ:BCYC) and Histogen (NASDAQ:HSTO) Head-To-Head Comparison
Histogen (NASDAQ:HSTO – Get Rating) and Bicycle Therapeutics (NASDAQ:BCYC – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations. Risk & Volatility Histogen has a beta of 1.33, suggesting […]
Source: etfdailynews.com
Reviewing Kronos Bio (NASDAQ:KRON) and Bicycle Therapeutics (NASDAQ:BCYC)
Kronos Bio (NASDAQ:KRON – Get Rating) and Bicycle Therapeutics (NASDAQ:BCYC – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends and institutional ownership. Institutional and Insider Ownership 63.4% of Kronos Bio shares […]
Source: kopsource.com